Cysteamine treatment ameliorates alterations in GAD67 expression and spatial memory in heterozygous reeler mice.

Brain-derived neurotrophic factor (BDNF) signalling through its receptor, TrkB is known to regulate GABAergic function and glutamic acid decarboxylase (GAD) 67 expression in neurons. Alterations in BDNF signalling have been implicated in the pathophysiology of schizophrenia and as a result, they are a potential therapeutic target. Interestingly, heterozygous reeler mice (HRM) have decreased GAD67 expression in the frontal cortex and hippocampus and they exhibit many behavioural and neurochemical abnormalities similar to schizophrenia. In this study, we evaluated the potential of cysteamine, a neuroprotective compound to improve the deficits in GAD67 expression and cognitive function in HRM. We found that cysteamine administration (150 mg/kg.d, through drinking water) for 30 d significantly ameliorated the decreases in GAD67, mature BDNF and full-length TrkB protein levels found in frontal cortex and hippocampus of HRM. A significant attenuation of the increased levels of truncated BDNF in frontal cortex and hippocampus, as well as truncated TrkB in frontal cortex of HRM was also observed following cysteamine treatment. In behavioural studies, HRM were impaired in a Y-maze spatial recognition memory task, but not in a spontaneous alternation task or a sensorimotor, prepulse inhibition (PPI) procedure. Cysteamine improved Y-maze spatial recognition in HRM to the level of wide-type controls and it improved PPI in both wild-type and HRM. Finally, mice deficient in TrkB, showed a reduced response to cysteamine in GAD67 expression suggesting that TrkB signalling plays an important role in GAD67 regulation by cysteamine.

[1]  M. Webster,et al.  Decreased BDNF, trkB-TK+ and GAD67 mRNA expression in the hippocampus of individuals with schizophrenia and mood disorders. , 2011, Journal of psychiatry & neuroscience : JPN.

[2]  M. Frotscher,et al.  Region‐specific alteration of GABAergic markers in the brain of heterozygous reeler mice , 2011, The European journal of neuroscience.

[3]  E. Tongiorgi,et al.  Low serum truncated-BDNF isoform correlates with higher cognitive impairment in schizophrenia. , 2011, Journal of psychiatric research.

[4]  Ingo Fründ,et al.  Human gamma-band activity: A review on cognitive and behavioral correlates and network models , 2010, Neuroscience & Biobehavioral Reviews.

[5]  Sarah E. Forster,et al.  Subunit-selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia. , 2008, The American journal of psychiatry.

[6]  K. Dhandapani,et al.  Cystamine prevents haloperidol‐induced decrease of BDNF/TrkB signaling in mouse frontal cortex , 2008, Journal of neurochemistry.

[7]  D. Lewis,et al.  GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia. , 2008, Schizophrenia bulletin.

[8]  S. Mahadik,et al.  Increased truncated TrkB receptor expression and decreased BDNF/TrkB signaling in the frontal cortex of reeler mouse model of schizophrenia , 2008, Schizophrenia Research.

[9]  C. Carter,et al.  Impairments in frontal cortical γ synchrony and cognitive control in schizophrenia , 2006, Proceedings of the National Academy of Sciences.

[10]  J. Lieberman,et al.  Typical and atypical antipsychotic drug effects on locomotor hyperactivity and deficits in sensorimotor gating in a genetic model of NMDA receptor hypofunction , 2006, Pharmacology Biochemistry and Behavior.

[11]  David A Lewis,et al.  Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations. , 2006, Archives of neurology.

[12]  A. Nairn,et al.  Assessment of cognitive function in the heterozygous reeler mouse , 2006, Psychopharmacology.

[13]  S. Akbarian,et al.  Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders , 2006, Brain Research Reviews.

[14]  E. Hirsch,et al.  Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase. , 2006, The Journal of clinical investigation.

[15]  E. Weeber,et al.  Cognitive disruption and altered hippocampus synaptic function in Reelin haploinsufficient mice , 2006, Neurobiology of Learning and Memory.

[16]  Hongjun Song,et al.  GABA regulates synaptic integration of newly generated neurons in the adult brain , 2006, Nature.

[17]  Bai Lu,et al.  Regulation of Cortical Interneurons by Neurotrophins: From Development to Cognitive Disorders , 2006, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[18]  J. Waller,et al.  Chronic exposure to typical or atypical antipsychotics in rodents: Temporal effects on central α7 nicotinic acetylcholine receptors , 2005, Neuroscience.

[19]  J. Kleinman,et al.  Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia , 2005, Molecular Psychiatry.

[20]  A. Sampson,et al.  Relationship of Brain-Derived Neurotrophic Factor and Its Receptor TrkB to Altered Inhibitory Prefrontal Circuitry in Schizophrenia , 2005, The Journal of Neuroscience.

[21]  R. Hughes.  The value of spontaneous alternation behavior (SAB) as a test of retention in pharmacological investigations of memory , 2004, Neuroscience & Biobehavioral Reviews.

[22]  R. Marc,et al.  Functionally intact glutamate-mediated signaling in bipolar cells of the TRKB knockout mouse retina. , 2004, Visual neuroscience.

[23]  M. Didriksen,et al.  The heterozygous reeler mouse: behavioural phenotype , 2004, Behavioural Brain Research.

[24]  W. Salinger,et al.  Behavioral phenotype of the reeler mutant mouse: effects of RELN gene dosage and social isolation. , 2003, Behavioral neuroscience.

[25]  M. van den Buuse,et al.  Impaired spatial reference memory in aromatase-deficient (ArKO) mice , 2003, Neuroreport.

[26]  G. Johnson,et al.  Cystamine Inhibits Caspase Activity , 2003, The Journal of Biological Chemistry.

[27]  M. Yamada,et al.  Brain-Derived Neurotrophic Factor Promotes the Maturation of GABAergic Mechanisms in Cultured Hippocampal Neurons , 2002, The Journal of Neuroscience.

[28]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[29]  C. Pesold,et al.  Reelin in the extracellular matrix and dendritic spines of the cortex and hippocampus: a comparison between wild type and heterozygous reeler mice by immunoelectron microscopy , 2001, Journal of neurocytology.

[30]  E. Costa,et al.  Down-regulation of dendritic spine and glutamic acid decarboxylase 67 expressions in the reelin haploinsufficient heterozygous reeler mouse , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Yogesh K. Dwivedi,et al.  Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. , 2000, Archives of general psychiatry.

[32]  K Maeda,et al.  Abnormal expression of brain-derived neurotrophic factor and its receptor in the corticolimbic system of schizophrenic patients , 2000, Molecular Psychiatry.

[33]  G. Koob,et al.  Genetic Differences in Response to Novelty and Spatial Memory Using a Two-Trial Recognition Task in Mice , 2000, Neurobiology of Learning and Memory.

[34]  C. Rodolfo,et al.  Inhibition of “Tissue” Transglutaminase Increases Cell Survival by Preventing Apoptosis* , 1999, The Journal of Biological Chemistry.

[35]  L. Maffei,et al.  BDNF Regulates the Maturation of Inhibition and the Critical Period of Plasticity in Mouse Visual Cortex , 1999, Cell.

[36]  Yogesh K. Dwivedi,et al.  The phenotypic characteristics of heterozygous reeler mouse. , 1999, Neuroreport.

[37]  N. Seidah,et al.  Mammalian subtilisin/kexin isozyme SKI-1: A widely expressed proprotein convertase with a unique cleavage specificity and cellular localization. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[38]  C. Sotelo,et al.  Regional and Cellular Patterns of reelin mRNA Expression in the Forebrain of the Developing and Adult Mouse , 1998, The Journal of Neuroscience.

[39]  K. Minor,et al.  Cysteamine Blocks Amphetamine-Induced Deficits in Sensorimotor Gating , 1997, Pharmacology Biochemistry and Behavior.

[40]  J. Crawley,et al.  Inbred strain differences in prepulse inhibition of the mouse startle response , 1997, Psychopharmacology.

[41]  T. Yagi,et al.  Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[42]  Bruce S. McEwen,et al.  The effects of Type I and Type II corticosteroid receptor agonists on exploratory behavior and spatial memory in the Y-maze , 1997, Brain Research.

[43]  E. Arenas,et al.  Effects of BDNF and NT‐4/5 on Striatonigral Neuropeptides or Nigral GABA Neurons In Vivo , 1996, The European journal of neuroscience.

[44]  A. Kriegstein,et al.  GABA and glutamate depolarize cortical progenitor cells and inhibit DNA synthesis , 1995, Neuron.

[45]  T. Curran,et al.  A protein related to extracellular matrix proteins deleted in the mouse mutant reeler , 1995, Nature.

[46]  H. Nawa,et al.  Brain-derived neurotrophic factor promotes differentiation of striatal GABAergic neurons. , 1994, Developmental biology.

[47]  D. E. Morse,et al.  Nicotine increases sensory gating measured as inhibition of the acoustic startle reflex in rats , 1994, Psychopharmacology.

[48]  M. Le Moal,et al.  A two-trial memory task with automated recording: study in young and aged rats , 1992, Brain Research.

[49]  Christian Grillon,et al.  Gating and habituation of the startle reflex in schizophrenic patients. , 1992 .

[50]  E. Soriano,et al.  Age-dependent spontaneous hyperexcitability and impairment of GABAergic function in the hippocampus of mice lacking trkB. , 2006, Cerebral cortex.

[51]  C. Carter,et al.  Impairments in frontal cortical gamma synchrony and cognitive control in schizophrenia. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[52]  Douglas Wahlsten,et al.  Different data from different labs: lessons from studies of gene-environment interaction. , 2003, Journal of neurobiology.

[53]  M. Geyer,et al.  Mouse genetic models for prepulse inhibition: an early review , 2002, Molecular Psychiatry.

[54]  R. Schreiber,et al.  Effects of alpha 4/beta 2- and alpha 7-nicotine acetylcholine receptor agonists on prepulse inhibition of the acoustic startle response in rats and mice. , 2002, Psychopharmacology.

[55]  A. Kriegstein,et al.  Developmental Neurotransmitters? , 2002, Neuron.

[56]  R. Schreiber,et al.  Effects of α4/β2- and α7-nicotine acetylcholine receptor agonists on prepulse inhibition of the acoustic startle response in rats and mice , 2001, Psychopharmacology.

[57]  R Freedman,et al.  Schizophrenia, sensory gating, and nicotinic receptors. , 1998, Schizophrenia bulletin.

[58]  P. Spoerri.  Neurotrophic effects of GABA in cultures of embryonic chick brain and retina , 1988, Synapse.